Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B - LGND - stock price prediction, stock price target, analyst ratings from 7 analysts
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B has a share price target of US$ 144, revenue growth forecast of 14.7%, and profit growth estimate of 1355.3% for FY25, based on top 7 analyst calls.